Patents by Inventor Chiara Mazzanti

Chiara Mazzanti has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHOD FOR DIAGNOSING THE STAGE OF A THYROID TUMOR
    Publication number: 20110177971
    Abstract: The present invention relates to the use of genes differentially expressed in benign thyroid lesions and malignant thyroid lesions for the diagnosis and staging of thyroid cancer.
    Type: Application
    Filed: February 10, 2011
    Publication date: July 21, 2011
    Inventors: Steven K. Libutti, Chiara Mazzanti, Martha Zeiger, Christopher Umbricht
  • Diagnostic tool for diagnosing benign versus malignant thyroid lesions
    Patent number: 7901881
    Abstract: The present invention relates to the use of genes differentially expressed in benign thyroid lesions and malignant thyroid lesions for the diagnosis and staging of thyroid cancer.
    Type: Grant
    Filed: April 11, 2005
    Date of Patent: March 8, 2011
    Assignees: The United States of America as represented by the Department of Health and Human Services, The John Hopkins University
    Inventors: Steven K. Libutti, Chiara Mazzanti, Martha Zeiger, Christopher Umbricht
  • Diagnostic Tool For Diagnosing Benign Versus Malignant Thyroid Lesions
    Publication number: 20080145841
    Abstract: The present invention relates to the use of genes differentially expressed in benign thyroid lesions and malignant thyroid lesions for the diagnosis and staging of thyroid cancer.
    Type: Application
    Filed: April 11, 2005
    Publication date: June 19, 2008
    Inventors: Steven K. Libutti, Chiara Mazzanti, Martha Zeiger, Christopher Umbricht
  • Methods for detecting nucleic acid sequence variation
    Patent number: 7273699
    Abstract: Sequence variations, such as polymorphisms, are detected by detecting differences between or among melting profiles of plural nucleic acids. Melting profiles are produced by observing the nucleic acids during a temperature change over a period of time. If the nucleic acids are diluted into solutions for analysis, the nucleic acid concentrations between or among the solutions can be substantially the same. The melting profiles and sequence variation can be used to identify changes in a wild-type nucleic acid sequence, such as a single-nucleotide polymorphism (SNP), a small insertion or deletion, or a small inversion.
    Type: Grant
    Filed: July 25, 2002
    Date of Patent: September 25, 2007
    Assignee: The United States of America as Represented by the Secretary of the Department of Health and Human Services
    Inventors: Robert H. Lipsky, Chiara Mazzanti, David Goldman